Adherence of Neisseria gonorrhoeae to host cells is facilitated by pili (30, 33, 46, 50) and possibly by a 36,000-Da adhesin molecule that binds to glycolipid receptors on mammalian epithelial cells (31) . Certain carbohydrate structures may act as receptors for gonococci and other Neisseria species (29, 41) . In addition, the presence of outer membrane protein PII, or Opa protein (Opa), on the gonococcal surface has been correlated with attachment of N. gonorrhoeae to many cell types, including urogenital cells, HeLa cells, conjunctival cells, and buccal epithelial cells (3, 13, 21, 30, 42) . Opa appears to be the primary mediator of the interactions of gonococci with human neutrophils (10, 18, 19, 39, 44, 45, 49) .
Opas undergo antigenic and phase variation at a frequency of 0.2 x 10-3 to 4.0 x 10-3 per cell per generation (27, 28, 40, 48, 53) . This variation leads to the addition or deletion of one or more Opas upon daily clonal subculture, which in turns leads to the formation of colonies of various opacities and antigenicities. Swanson and colleagues originally described a specific Opa, termed leukocyte association protein, that was not associated with opacity (19, 44, 45) . Apparently, only certain Opas, defined by their electrophoretic mobility in polyacrylamide gels and antibody reactivity, are associated with increased leukocyte or epithelial cell association (49, 51). Fischer (13) . Thus, gonococcal colony opacity per se cannot be directly related to neutrophil adherence.
Investigation of the role of Opa proteins in gonococcusneutrophil interactions has been hampered by the insolubility of purified Opa in the absence of detergents (11, 18) ; therefore, no studies have been performed with purified * Corresponding author.
Opa. However, indirect techniques, such as (i) use of anti-Opa monoclonal antibodies to inhibit gonococcal adherence to human epithelial cells or neutrophils, or to inhibit stimulation by gonococci of human neutrophil oxidative metabolism (2, 10, 42, 49) ; (ii) use of carbohydrates and glycosidases to block gonococcal stimulation of neutrophils (36) ; and (iii) use of proteases to inhibit gonococcal adherence to neutrophils (9) , have been used.
To better understand the molecular mechanisms of Opamediated gonococcal interactions with neutrophils, we investigated the abilities of gonococcal outer membranes, purified Opa in detergent, purified Opa inserted into liposomes (Opa+ lips), and synthetic peptides (composing the second hypervariable [HV2] region of OpaB from strain FA1090) associated with liposomes (pepHV2 lips) to adhere to neutrophils. Outer membranes, Opa, Opa+ lips, and pepHV2 lips were also tested for their abilities to inhibit subsequent gonococcal adherence to neutrophils. On the basis of the results of these studies, we conclude that purified Opa can be used as a tool to investigate its mechanism of action and that the HV2 region mediates at least some of the biological activity of Opa proteins.
MATERIALS AND METHODS
Bacteria. N. gonorrhoeae F62 and FA1090 were maintained by daily passage on GC agar base (Difco Laboratories, Detroit, Mich.) with added growth supplements, as previously described (34, 37) . Colony type was identified by criteria established by Kellogg et al. (17) and Swanson (43) . Only nonpiliated gonococci were used in these studies. The Opa content of the variants was checked regularly by electrophoresis through polyacrylamide gels (see below) and reactivity with anti-Opa antisera or monoclonal antibodies (MAbs) (10) . Table 1 lists the Opa variants used in these studies and their abilities to adhere to neutrophils. For daily use, gonococci were grown to mid-log phase in GC broth (GC base without agar) with added supplements at 37°C for 3 to 4 h in a shaking water bath, washed once in phosphatebuffered saline (PBS) containing 0.1% gelatin (PBSG; pH 7.4), resuspended to 2 x 108 to 4 x 108 CFU/ml, and held at room temperature (37) . SDS-PAGE. Samples for sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) were incubated in equal volumes of 2 x SDS-prep buffer at 100°C for 5 min or 37°C for 60 min, as indicated in the text, and run on 12% gels by the method of Laemmli (20) . All material for SDS-PAGE was purchased from Bio-Rad (Richmond, Va.). Gels were consecutively stained with silver by the method of Tsai and Frasch (47) and Coomassie brilliant blue by methods described in the Bio-Rad electrophoresis instruction manual.
Monitoring LOS phenotype. Throughout these studies, gonococcal lipooligosaccharide (LOS) phenotype was monitored by running whole-cell preparations, treated with proteinase K, on Tricine-SDS-polyacrylamide gels as described by Lesse et al. (23) . Strains F62 and FA1090 had different LOS phenotypes, whereas FA1090 OpaA and OpaB had the same LOS phenotype. Most importantly, LOS phenotypes of the different variants did not change during the course of the studies.
Isolation of gonococcal outer membranes. Outer membranes were prepared by the LiCl2 extraction procedure described by Leith and Morse (22) . Outer membranes were washed once in water and resuspended in water by Dounce homogenization to a protein concentration of 1 to 3 mg/ml (24 (4) .
For the purpose of this report, purified OpaBFA109, OPaAFA1090 , and Opa4F62 will be referred to as OpaB, OpaA, and Opa4, respectively.
Liposomes. Lipid stock solutions (10 mM in chloroform) were pipetted into 25-ml pear-shaped flasks in molar ratios of 2:1.5:0.22, phosphatidylcholine-cholesterol-dicetyl phosphate. The chloroform was rotoevaporated at 30°C (32, 38) , and 1.0 ml of liposome buffer (0.14 M NaCl in 10 Mm Tris HCl buffer, pH 7.4) and several borosilicate glass beads (precoated with 1% BSA) were added. The contents were then vortexed to remove all phospholipid from the flask walls. Purified Opa (100 ,ug) and liposome buffer were then added to bring the total volume of the suspension to 2.0 ml. Subsequently, the mixture was sonicated at room temperature for 2 to 4 min to form a very slightly turbid suspension of small, unilamellar liposomes (15, 16) . A typical liposome preparation used a total of 2.5 ml of lipids in chloroform, 200 ,ul of purified Opa, and 1.8 ml of liposome buffer. Liposomes were made fresh daily and kept at room temperature until use. All lipids were purchased from Avanti Polar Lipids, Birmingham, Ala.
Peptides. Three 15-amino-acid peptides were synthesized by Jan Pohl, Microchemical Facility, Emory University School of Medicine, Atlanta, Ga., by standard t-Boc chemistry. Purity was confirmed by high-performance liquid chromatography performed at the time of synthesis. The peptides were sent as lyophilized powders and stored desiccated at 4°C. The peptides, designated pepHV2-A, pepHV2-B, and pepHV2-C, were overlapping and encompass the entire HV2 region of FA1090 OpaB as described by Connell et al. (6) . pepHV2-A consists of amino acids 149 to 163 (SIDSTKKITGTLTAY), pepHV2-B consists of amino acids 161 to 175 (TAYPSDADAAVTVYP), and pepHV2-C consists of amino acids 174 to 188 (YPDGHPQKNTYQKSN).
Neutrophils. Human neutrophils were purified from freshly heparinized venous blood by a single centrifugation through Ficoll-Hypaque, as described by Ferrante and Thong (12) . Erythrocytes were lysed once by exposure to cold water for 15 s. Neutrophil suspensions were .94% pure as determined by Wright's stain and .98% viable as determined by exclusion of 0.25% trypan blue in saline at room temperature. Purified neutrophils were suspended to 107/ml in PBSG and kept on ice until use.
Gonococcal adherence to neutrophils. Adherence assays were performed in 1.5-ml snap-cap tubes with 5 x 105 neutrophils and 2 x 107 gonococci in PBSG to a final volume of 1 ml. Incubations were at 37°C unless indicated otherwise. Neutrophils were pretreated with 5 ,ug of cytochalasin B per ml (5-mg/ml stock in dimethyl sulfoxide [DMSO]) for 5 min to prevent phagocytosis and 10 to 20 ng of phorbol myristate acetate (PMA; 100-,ug/ml stock in DMSO) for 5 min to increase the number of Opa receptors on the neutrophil surface (11) . To test the effect of outer membranes, purified Opa, Opa+ lips, or pepHV2 lips on the ability of gonococci to adhere to neutrophils, they were preincubated with neutrophils for 20 min before the addition of gonococci. After addition of gonococci, mixtures were tumbled end over end (10 to 20 rpm) for an additional 20 to 30 min, at which time 150 ,ul was withdrawn and deposited on a microscope slide with a cytocentrifuge (Shandon Southern Corp., Sewickley, Pa.). Samples were air dried and stained with Wright's stain, and adherence was quantitated by light microscopy (100x, oil immersion) by counting the number of adherent gonococci per 100 neutrophils in contiguous fields. Results are expressed as the average number of gonococci per neutrophil or as percentage of control adherence (untreated neutrophils and untreated gonococci).
Binding of purified Opa proteins to neutrophils. Neutrophils were pretreated with 5 ,ug of cytochalasin B per ml (5-mg/ml stock in DMSO) for 5 min to prevent phagocytosis and 10 to 20 ng of PMA (100-,ug/ml stock in DMSO) for 5 min to increase the number of Opa receptors on the neutrophil surface (11) . To test the ability of purified Opa proteins to bind to neutrophils, 3 pug of purified OpaA or OpaB was added to various amounts of neutrophils (total volume of 1 ml in PBSG) for 20 min. To decrease nonspecific binding of the proteins to the sides of the tubes, all tubes were first rinsed with 6% BSA (in PBSG) and then washed twice with PBSG. The suspension was then centrifuged at 6,000 x g for 6 min at room temperature. The supernatants were carefully aspirated and placed in a clean microcentrifuge tube, while the pellets were resuspended to 1 ml in PBSG. An aliquot from each tube was then removed and mixed with 2 x SDS-sample buffer and a SDS-12% polyacrylamide gel was run. Proteins were then electroblotted to nitrocellulose, and the blot was probed with either Opa-specific MAbs or anti-Opa rabbit antiserum (PI14-1 [see below]). The blots were developed by using enhanced chemiluminescence (ECL protein detection kit; Amersham, Arlington Ijeights, MAbs and serum. MAb 53C4 was provided by Charles E. Wilde, Indiana University School of Medicine, Indianapolis, as ascitic fluid (28) . MAb 10.1 was supplied by Janne Cannon, University of North Carolina School of Medicine, Chapel Hill, as hybridoma culture supernatant (42) . Both are immunoglobulin G2a and react with Opa4 and OpaB gonococci on Western blots and in a whole-cell binding assay (2, 10) and inhibit Opa4 and OpaB gonococci from adhering to and stimulating neutrophil CL (10, 36) . Antiserum P114-1 was raised by conventional techniques in rabbits against partially purified P114 (Opa4) from strain F62. Antiserum PI14-1 reacts with Opa4 and OpaB on colony, dot, and Western blots and also recognizes OpaA (the nonadherent Opa of strain FA1090) on Western blots.
Statistical analysis. Where appropriate, experimental data were compared to appropriate controls by using the Student t test for paired samples.
RESULTS
Purification of Opa proteins and outer membranes. Purification of Opa proteins proceeded as described by Newhall et al. (28) . The individual gonococcal Opa variants used in these studies contained only one Opa protein, as did their respective outer membranes. Opa4 was purified to apparent homogeneity as observed on Coomassie blue-silver doublestained SDS-polyacrylamide gels (Fig. 1) . Western blots, with Opa-specific MAbs or antiserum PI14-1, were done to confirm which Opa proteins were being used (data not shown). No LOS was detected in the Opa preparations as determined by Tricine-SDS-PAGE and subsequent silver staining (data not shown).
Role of Opa in adherence of gonococci to neutrophils. To investigate whether Opa proteins could bind to neutrophils in either a semipurified or purified state, we examined the ability of gonococcal outer membranes or purified Opas to inhibit subsequent binding of viable Opa+ gonococci to neutrophils. Outer membranes from OpaB-containing gonococci, in a dose-responsive manner, significantly inhibited the subsequent binding of OpaB gonococci to neutrophils (Fig. 2) . Although at higher concentrations outer membranes from strain FA1090 containing no Opa proteins (Opa neg) or outer membranes from OpaA-containing gonococci also inhibited adherence of OpaB gonococci to neutrophils, they did so to a significantly lower degree than did outer membranes containing OpaB (Fig. 2) of gonococci to neutrophils (13) . Further analysis demonstrated that all outer membrane preparations, regardless of Opa content, were increasingly toxic to neutrophils at a concentration of .25 ,ug/ml (Fig. 3) . This possibly explains the inhibitory action of Opa neg and OpaA outer membranes at higher concentrations. We conclude from these set of experiments that (i) Opa proteins remain biologically active in outer membranes, (ii) the ability of outer membranes to inhibit subsequent gonococcal binding to neutrophils is directly related to the presence of Opa, and (iii) gonococcal viability is not required for Opa function.
Since Adherence of purified Opa proteins to neutrophils. Purified OpaB or OpaA (3 ,ug of each) was added to increasing numbers of cytochalasin B-and PMA-treated neutrophils. Suspensions were incubated for 20 min and then centrifuged (6,000 x g, 6 min, room temperature). Aliquots of supernatants and pellets were subjected to SDS-12% PAGE before being electroblotted to nitrocellulose. Blots were probed with either anti-Opa MAb 53C4 for OpaB or anti-Opa rabbit antiserum P114-1 for OpaA and were developed by using enhanced chemiluminescence. (A) Results of a representative experiment using purified OpaB; (B) results of a representative experiment using purified OpaA. maximum of about 50% (Fig. 4) . Similarly, OpaB inhibited OpaB gonococci from adhering to neutrophils. On the other hand, OpaA had no effect on adherence of either strain FA1090 OpaB (Fig. 4) or strain F62 Opa4 (data not shown). Of importance is the fact that none of the Opa proteins were toxic for neutrophils at the concentrations used. For reasons that remain unclear, we never saw more than 55% inhibition of adherence by purified Opas.
Interestingly, purified OpaB also inhibited subsequent adherence to neutrophils of Opa4 gonococci (data not shown). This supports the idea that there is a shared binding epitope(s) between certain Opa variants of different gonococcal strains, as described by Elkins and Rest (10) , who showed that anti-Opa MAb 53C4 recognizes both Opa4 and OpaB gonococci on Western blots, inhibits Opa4-and OpaBmediated gonococcal binding to neutrophils, and inhibits Opa4-and OpaB-mediated gonococcal stimulation of neutrophil CL. These results also support the idea of a shared receptor for Opa proteins on the human neutrophil surface (11) .
To further define the biological activity of purified Opa proteins, we investigated their ability to bind directly to neutrophils. By using a simple centrifugation assay, described in Materials and Methods, we observed that purified OpaB (3 ,ug) bound, in a dose-responsive manner, to increasing numbers of neutrophils (Fig. 5) . Conversely, OpaA, which does not mediate adherence of OpaA gonococci to neutrophils, did not bind to neutrophils (Fig. 5) To indicate that Opa was indeed associated with liposomes, 1-ml suspensions of Opa+ lips were centrifuged at 170,000 x g for 2 h, the supernatants were saved, and the resultant pellets were resuspended in 1 ml of water. Samples of the starting liposome suspension, the resuspended liposome pellets, and the liposome-free supernatant were then run on SDS-PAGE. Opa was found in the Opa+ lips suspension and the resuspended pellets but not in the supematants, indicating that Opa was indeed associated with the liposomes (data not shown). Purified Opa proteins in 1% octylglucoside are not pelleted under these conditions. Effect of OpaB peptides on gonococcal adherence to neutrophils. To begin characterizing the domain(s) on the Opa molecule involved in gonococcal adherence to neutrophils, we tested the ability of three 15-amino-acid peptides composing the HV2 region of OpaB to inhibit gonococcal adherence to neutrophils. The peptides were designated pepHV2-A, -B, and -C, as described in Materials and Methods. This approach was chosen because it appears that a major structural difference between adherent OpaB and nonadherent OpaA resides in or around the peptide sequence of the HV2 region (1, 6, 7, 13) . Initial attempts to use pure peptides yielded inconsistent and uninterpretable results. In an attempt to overcome these problems, we associated the peptides with liposomes (pepHV2 lips) as described above with purified Opa. We then performed experiments similar to those described above for Opa+ lips. Neutrophils were preincubated with pepHV2 lips before the addition of gonococci. The results show that liposomes containing pepHV2-A or pepHV2-C, the peptides composing the amino and carboxyl ends, respectively, of the HV2 region of OpaB, inhibited OpaB-mediated gonococcal adherence to neutrophils (Table 3) . On the other hand, liposomes containing HV2-B (which composes the middle of the HV2 region of OpaB) or peptide-free liposomes did not (Table 3) . When pepHV2-A and pepHV2-C lips were mixed together at relatively low volumes (<25 ,ul each), additive inhibition was seen. At higher volumes (>25 ,lI each) the liposomes were toxic to neutrophils (data not shown).
We conclude from these experiments that there may be multiple epitopes involved in Opa- (13, 19, 35, 36, 45, 49) . By using Opa+ outer membranes, Opa+ lips, and peptides from the HV2 region of OpaB (from strain FA1090), we were able to study the function of the Opa protein as well as begin to identify the specific region(s) on the Opa molecule which acts as the gonococcal ligand for the neutrophil Opa receptor(s). To reach this goal, we investigated Opamediated gonococcal adherence to human neutrophils in the presence of cytochalasin B, which inhibits the ability of neutrophils to phagocytose adherent gonococci (8, 35) but does not affect the ability of gonococci to adhere to neutrophils (11) .
The studies presented here show that Opa-containing outer membranes, purified Opa, and Opa+ lips inhibited subsequent adherence of gonococci to neutrophils. This was true for all Opa proteins tested except for OpaAFA10%, which does not mediate adherence of gonococci to neutrophils. It is reasonable to assume from the data that the Opa protein is, in fact, the only gonococcal surface component responsible for gonococcal adherence to neutrophils (13) .
Similar to Opa proteins and pili, gonococcal LOS undergoes frequent antigenic variation (25) . We do not think that LOS is involved with the observations presented in this paper, however, since we monitored LOS phenotype throughout the studies. Although the LOS phenotypes of strains FA1090 and F62 were different (as would be expected with the high degree of LOS variation), the LOS phenotypes of FA1090 OpaA and OpaB variants were the same. Most importantly, the LOS phenotypes of the different Opa variants remained constant throughout the studies. This does not preclude, however, that LOS may be involved in modulating Opa-mediated adherence to neutrophils. Such controlled studies remain to be performed.
Farrell and Rest showed that human peripheral blood neutrophils bind substantially more Opa+ gonococci after incubation with any of a number of potent neutrophilstimulating agents, including the chemoattractant peptide formylmethionylleucylphenylalanine, the calcium ionophore A23187, and the cocarcinogen PMA (11) . It was concluded from these observations that Opa receptors (as yet unidentified) were located within the membranes of specific granules and were being brought to the surface of the activated neutrophils (11) . All of the experiments presented in the current work were performed with such stimulated neutrophils. Exudate neutrophils, e.g., neutrophils found in the urethra or cervix during gonorrhea, are naturally activated in that, during diapedesis and chemotaxis, they are induced to degranulate (release) some or all of their specific granule contents (52) . Therefore, our use of activated neutrophils, as opposed to resting peripheral blood neutrophils, probably more accurately reflects gonococcus-neutrophil interactions occurring during gonorrhea.
Although we performed no formal studies as to the orientation of the Opa protein within or on the prepared liposomes, the data seem to preclude any conclusion other than that at least some of the Opa molecules were in a functionally active orientation. If they were not, the Opa+ lips would have been expected to function in a manner similar to the protein-free liposomes. In fact, the mere presence of the Opa protein in or on liposomes was not responsible for their ability to inhibit subsequent gonococcal binding to neutrophils, since liposomes containing the nonadherent Opa protein, OpaA, acted similarly to protein-free liposomes.
Opa proteins, which actually compose a group of related basic proteins with apparent molecular masses of 24 to 30 kDa as determined by SDS-PAGE, were first described by Swanson as opacity-associated proteins (43) . DNA sequencing of Opa genes by Stern et al. (40) , later confirmed by Connell et al. (6, 7) , has shown that Opa proteins exhibit near homology except at three areas: the semivariable region near the N terminus and two hypervariable regions termed HV1 and HV2. On the basis of amino acid sequences and immunologic detection, the two hypervariable regions are thought to be surface exposed (40) . MAb 10.1, which is directed against an epitope on the OpaB protein (1), inhibits OpaB-containing gonococci from binding to and stimulating human neutrophils (9) . Interestingly, MAb 10.1 also inhibits Opa4-containing gonococci from binding to and stimulating human neutrophils (9) . F62 is unrelated to strain FA1090, and this evidence suggests shared epitopes between Opa proteins of different gonococcal strains. Supporting this notion, Elkins and Rest showed that MAb 53C4, which was derived from mice immunized against intact strain F62 gonococci, also inhibits adherence to and stimulation of human neutrophils by both Opa4-and OpaB-containing gonococci (10) . These data strongly suggest that Opa4 and OpaB share the same neutrophil binding epitope(s) or that they are, in fact, the same Opa protein.
Characterization of MAb 10.1 suggests that it binds to an area proximal to the carboxyl terminus of the HV2 region of OpaB (1, 7) . On the basis of this information, we synthesized peptides which encompassed the entire HV2 region of OpaB as well as a few adjacent amino acids. The peptides were 15 amino acids long and arbitrarily designated pepHV2-A, pepHV2-B, and pepHV2-C. Although none of the peptides in solution consistently inhibited subsequent gonococcal adherence to neutrophils, liposomes that individually incorporated each of the peptides proved to be useful tools. While both pepHV2-A lips and pepHV2-C lips inhibited subsequent gonococcal adherence to neutrophils, pepHV2-B lips had no inhibitory effect. According to the two-dimensional model of the gonococcal Opa protein described by Stern et al. (40) , there appear to be at least two surface-exposed loops and one possible intramembrane loop of the Opa protein when it is in the gonococcal membrane. Our own hydrophobicity plots of the HV2 region of OpaB suggest that the HV2 region also has two surface-exposed loops and one intramembrane loop. pepHV2-A contains the amino acids that make up the first surface-exposed loop, pepHV2-B contains the amino acids which make up the intramembrane loop, and pepHV2-C contains the amino acids that make up the second surface-exposed loop. Therefore, our results suggest that both surface-exposed areas may be involved in adherence of N. gonorrhoeae to human neutrophils but that both are not required. While the results obtained by using MAb 10.1 suggest that there is a single binding epitope, it is possible that there exists a multivalent epitope consisting of both surfaceexposed regions. Another possibility is that MAb 10.1 recognizes a single linear epitope, which may be located on one of the surface-exposed areas, and it simply sterically hinders other areas involved in binding. Further work at both the protein and molecular levels should elucidate the exact area(s) within the HV2 region that is ultimately responsible for adherence of N. gonorrhoeae to human neutrophils.
